Neurodevelopment Following Exposure to Antiseizure Medications in Utero: A Review
- PMID: 34279202
- PMCID: PMC9185783
- DOI: 10.2174/1570159X19666210716111814
Neurodevelopment Following Exposure to Antiseizure Medications in Utero: A Review
Abstract
Exposure in the womb to antiseizure medications and their potential impact on the brain of the developing child has long been researched. Despite this long period of interest, this review highlights that above the well-known risks associated with valproate exposure, there are more data required for conclusions regarding all other antiseizure medications. Limited experience with phenytoin and phenobarbital in monotherapy makes clearly defining the risk to later child postnatal functioning difficult, although the evidence of an impact is stronger for phenobarbital than for phenytoin. The widely prescribed lamotrigine is limited in its investigation in comparison to unexposed control children, and whilst it has been demonstrated to carry a lower risk than valproate for certain outcomes, whether it is associated with a more moderate impact on wider aspects of neurodevelopmental functioning is still to be understood. Data for levetiracetam, topiramate and oxcarbazepine are too limited to confidently draw conclusions for most neurodevelopmental outcomes. This slow accumulation of evidence impacts on the safest use of medications in pregnancy and makes counseling women regarding the risks and benefits of specific antiseizure medications difficult. Improved focus, funding, and research methodologies are urgently needed.
Keywords: Antiseizure medications; antiepileptic drugs; child development; epilepsy; neurodevelopment; pregnancy; teratology..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.Lancet Neurol. 2018 Jun;17(6):530-538. doi: 10.1016/S1474-4422(18)30107-8. Epub 2018 Apr 18. Lancet Neurol. 2018. PMID: 29680205
-
Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.BMJ Open. 2017 Jul 20;7(7):e017248. doi: 10.1136/bmjopen-2017-017248. BMJ Open. 2017. PMID: 28729328 Free PMC article. Review.
-
Neurodevelopmental outcomes in children exposed to newer antiseizure medications: A systematic review.Epilepsia. 2021 Aug;62(8):1765-1779. doi: 10.1111/epi.16953. Epub 2021 Jun 14. Epilepsia. 2021. PMID: 34128227 Review.
-
Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study.JAMA Neurol. 2022 Apr 1;79(4):370-379. doi: 10.1001/jamaneurol.2021.5487. JAMA Neurol. 2022. PMID: 35157004 Free PMC article.
-
Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure.N Engl J Med. 2024 Mar 21;390(12):1069-1079. doi: 10.1056/NEJMoa2309359. N Engl J Med. 2024. PMID: 38507750 Free PMC article.
Cited by
-
Perceived risk of neurodevelopmental outcomes in offspring related to psychotropic and mental illness exposures in pregnancy and breastfeeding: a cross-sectional survey of women with past or current mental illness.BMJ Open. 2022 Sep 30;12(9):e061159. doi: 10.1136/bmjopen-2022-061159. BMJ Open. 2022. PMID: 36180118 Free PMC article.
-
Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project.Drug Saf. 2023 May;46(5):479-491. doi: 10.1007/s40264-023-01291-7. Epub 2023 Mar 28. Drug Saf. 2023. PMID: 36976447 Free PMC article. Review.
-
Prevalence of self-reported emotional, physical, and sexual abuse and association with fear of childbirth in pregnant women with epilepsy: The Norwegian Mother, Father, and Child Cohort Study.Epilepsia. 2022 Jul;63(7):1822-1834. doi: 10.1111/epi.17242. Epub 2022 Apr 11. Epilepsia. 2022. PMID: 35352343 Free PMC article.
-
Neurotropic Drugs in Pregnancy and Lactation from the Point of View of the Clinical Teratologist.Curr Neuropharmacol. 2021;19(11):1792-1793. doi: 10.2174/1570159X1911211115145019. Curr Neuropharmacol. 2021. PMID: 34814813 Free PMC article. No abstract available.
-
Exposure to medication for neurological disease in pregnancy - time to consider the long-term implications?EClinicalMedicine. 2023 Aug 24;63:102157. doi: 10.1016/j.eclinm.2023.102157. eCollection 2023 Sep. EClinicalMedicine. 2023. PMID: 37662523 Free PMC article. Review.
References
-
- Vorhees C. 1986. Principles of behavioral teratology .